JOPIC

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

EndNote Style
Index
Original Article
Pre-pandemic early viral pneumonias; could we have encountered COVID-19 before? Accompanying a diagnostic model
Aims: COVID-19 shows overlapping clinical and radiological findings with other viral pneumonias. This study designed to explore the likelihood of the existence of COVID-19 pneumonia in our country before March 11th, date of first official COVID-19 case detected in Turkey, by using a diagnostic model designed with radiologic and laboratory findings.
Methods: 273 patients with pre-diagnosis of viral pneumonia were aggrouped according to hospitalization date (before and after 11March), naso-oropharyngeal swab PCR results. Thoracic tomographies, C-reactive protein (CRP), leukocyte, lymphocyte, monocyte, eosinophil, platelet values of all patients were evaluated.
Results: Laboratory findings of lymphocyte, eosinophil counts (p<0.05) were significantly low; radiologic findings of round opacity, cobblestone, nodüle, subpleural line were significant in COVID-19 group (p<0.05). ‘Round opacity’, ‘subpleural line’, ‘nodule’, ‘lymphocyte’ variables were found to be statistically significant for final model (p<0.05). COVID-19 diagnosis possibility; increases 302.9% by ‘round opacity’, 355.6% by ‘subpleural lines’; and decreases 59.1% by ‘nodule’ presence, 31.7% by one unit increase in lymphocyte level. Based on final model; 49.3% of the participants before 11 March 2020 were predicted to be positive for COVID-19.
Conclusion: According to these findings, we can say that COVID-19 patients existed before March 11th, 2020 in Turkey, for the first time. Also based on same diagnostic model; subpleural lines, presence of cobblestone, round opacity appearances and absence of nodules on tomography, and the presence of lymphopenia and eosinopenia in the cell count can also be used to support the diagnosis of COVID pneumonia.


1. The Johns Hopkins Center for Health Security (JHCHS) | Homepage [Internet]. [cited 2020 May 10]. https://www. centerforhealthsecurity.org/
2. Demirbilek Y, Pehlivant&uuml;rk G, &Ouml;zg&uuml;ler Z&Ouml;, Meşe EA. COVID-19 outbreak control, example of ministry of health of Turkey. Turk J Med Sci. 2020;50(SI-1):489-494. doi:10.3906/sag-2004-187
3. Burki T. China&rsquo;s successful control of COVID-19. Lancet Infec Dis. 2020; 20(11):1240-1241. doi:10.1016/S1473-3099(20)30800-8
4. McCombs A, Kadelka C. A model-based evaluation of the efficacy of COVID-19 social distancing, testing and hospital triage policies. PLoS Comput Biol. 2020;16(10):e1008388.doi:10.1371/journal.pcbi.1008388
5. Tan W, Zhao X, Ma X, et al. A novel coronavirus genome identified in a cluster of pneumonia cases- Wuhan, China 2019 2020. China CDC Wkly. 2020;2(4):61-62. doi:10.46234/ccdcw2020.017
6. Wynants L, Calster BV, Collins GS, et al. Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal.<strong> </strong>BMJ. 2020;369:m1328.doi:10.1136/bmj.m1328
7. Wellcome Trust. Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak 2020.https://wellcome.ac.uk/press-release/sharing-research-data-and-findings-relevant-novel-coronavirus-covid-19-outbreak
8. Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44-48. doi:10.1016/j.ijid.2020.03.004
9. Li LQ, Huang T, Wang YQ, et al. 2019 novel coronavirus patients&rsquo; clinical characteristics, discharge rate and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-583. doi:10.1002/jmv.25757
10. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548-551. doi:10.1002/jmv.25722
11. Tang X, Du R, Wang R, et al. Comparison of hospitalized patients with ARDS saused by COVID-19 and H1N1. Chest. 2020;158(1):195-205. doi: 10.1016/j.chest.2020.03.032
12. RuuskanenO, Lahti E, Jennings LC,David R, Murdoch DR. Viral pneumonia. Lancet. 2011;377(9773):1264-1275. doi:10.1016/S0140-6736 (10)61459-6
13. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
14. R Core Team (2020). R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. URL https://www.R-project.org/.
15. Rubin GD, Ryerson CJ, Haramati LB, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner society. Radiology. 2020;296(1): 172-180. doi:10.1148/radiol.2020201365
16. American College of Radiology. ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19. https://www.acr.org/AdvocacyandEconomics/ACRPositionStatements/Recommendations-forChest-Radiography-and-CT-for-Suspected-COVID19-Infection. Accessed 4 Apr 2020
17. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RTPCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296(2):E32-E40. doi:10.1148/radiol.2020200642
18. Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296(2):E115-E117. doi:10.1148/radiol.2020200432
19. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;296(2):E46-E54. doi:10.1148/radiol.2020200823
20. Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis. J Am Coll Radiol. 2020; 17(6):701-709. doi:10.1016/j.jacr.2020.03.006
21. Altmayer S, Zanon M, Pacini GS, et al. Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis. Eur Radiol. 2020;30(12):6485-6496. doi:10.1007/s00330-020-07018-x
22. Yin Z, Kang Z, Yang D, Ding S, Luo H, Xiao E. A comparison of clinical and chest CT findings in patients with influenza A (H1N1) virus infection and coronavirus disease (COVID-19). AJR Am J Roentgenol. 2020;215(5):1065-1071. doi:10.2214/AJR.20.23214
23. Wu J, Pan J, Teng D, Xu X, Jianghua Feng J, Chen YC. Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia. Eur Radiol. 2020;30(10):5455-5462. doi:10.1007/s00330-020-06915-5
24. Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID19) pneumonia. Radiology. 2020;295(3):715-721. doi:10.1148/radiol.2020200370
25. Franquet T. Imaging of pulmonary viral pneumonia. Radiology. 2011; 260(1):18-39. doi:10.1148/radiol.11092149
26. Liu M, Zeng W, Wen Y, Zheng Y, Lv F, Xiao K. COVID-19 pneumonia: CT findings of 122 patients and differentiation from İnfluenza pneumonia. Eur Radiol. 2020;30(10):5463-5469. doi:10.1007/s00330-020-06928-0
27. Franquet T, Muller NL, Gimenez A, Martinez S, Madrid M, Domingo P. Infectious pulmonary nodules in immunocompromised patients: usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr. 2003;27(4):461-468. doi:10.1097/00004728-200307000-00001
28. Lia Q, Dinga X, Xiab G, Chend HG, Chena F, Genga Z. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study EClinicalMedicine. 2020;23: 100375. doi:10.1016/j.eclinm.2020.100375
29. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1-7. doi:10.1016/j.jaci.2020.04.021
30. Jesenak M, Schwarze J. Lung eosinophils-A novel &ldquo;virus sink&rdquo; that is defective in asthma? Allergy. 2019;74(10):1832-1834. doi:10.1111/all.13811
31. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-1741. doi:10.1111/all.14238
32. Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020; 75(7):1564-1581. doi:10.1111/all.14364
33. Forstera P, Forsterd L, Renfrewb C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. PNAS. 2020;117(17):9241-9243. doi:10. 1073/pnas.2004999117
34. Fongaro G, Stoco PH, Souza DSM, et al. The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019. Sci Total Environ. 2021;778:146198. doi:10.1016/j.scitotenv.2021.146198
35. Basavaraju SV, Patton ME, Grimm K, et al. Serologic testing of US blood donations to ıdentify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019-January 2020.Clin Infect Dis. 2021;72(12):e1004-e1009. doi:10.1093/cid/ciaa1785
Volume 3, Issue 1, 2025
Page : 7-12
_Footer